Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.98, demonstrating a +1.32% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily ...

Special Report: LTR Pharma has co-founded and secured a 33% equity ownership in LevOmega, an Australian company focused on ...

Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

Verrica CEO Jayson Rieger said a $10 million payment from its licensing partner will immediately strengthen the firm's ...

Though supported by Big Pharmas like Sanofi and Novo Nordisk parent company Novo Holdings, MapLight has readily burned through heaps of cash. The biotech’s current deficit is $251.6 million as of June ...

Pfizer (PFE), a pharmaceutical and biotechnology company, rose to great heights during the pandemic with its COVID-19 vaccine ...

Innovative AI-powered monitoring enables a leading pharmaceutical and biotechnology company to optimize transport modes without compromising product integrity ...

Launching a therapy for a rare disease is both triumph and trial. The science is often dazzling, yet companies face the stark reality of vanishingly small patient pools, skeptical payers, and ...

A new training space for future biopharmaceutical employees is now operational at the Pitt County Technology Enterprise ...

GCCL, a global clinical trial sample analysis organization, announced on September 22 that on the 19th, it signed a ...

University of Maine researchers developed a new process to make HBL, a key ingredient in many medicines, from renewable ...

Two relatively unknown biotechs that are developing promising therapies in this field are Terns Pharmaceuticals ( TERN -7.64%) and Rhythm Pharmaceuticals ( RYTM -2.57%). These biotechs could soar ...